Listen

Description

In this episode, we dive into the use of sleep medications in psychiatry. Is insomnia a standalone condition or a symptom of deeper issues? We discuss our clinical approach to treating sleep disturbances in psychiatric patients, focusing on medications to the nuanced use of trazodone, gabapentin, and antihistamines. Along the way, we explore the intersections of sleep and psychiatric illnesses, and the role of medications in patient recovery.

What we cover

* Whether primary insomnia is a real condition: the DSM criteria (three nights a week for three months), the objection that it is a diagnosis of exclusion, and a model of stress insomnia turning chronic through habits and negative sleep thoughts.

* The Robins and Guze approach to diagnostic validity, and one host's argument that sleep research on primary insomnia rarely applies to psychiatric patients, who are usually excluded from those trials.

* Guideline-recommended sleep drugs (Z-drugs, dual orexin receptor antagonists, ramelteon, low-dose doxepin) set against what psychiatrists often use: trazodone, hydroxyzine, gabapentin, mirtazapine, quetiapine, melatonin and liquid doxepin.

* A sleep plan by diagnosis: anxiety, depression (REM and circadian changes), bipolar disorder, evening paranoia and hallucinations, and trauma nightmares, including prazosin, imagery rehearsal therapy and trauma-focused psychotherapy.

* Insomnia that starts on an SSRI, and what to rule out before prescribing: sleep apnea, circadian rhythm disorders, caffeine, alcohol, cannabis and late-night phone use.

* Why handing out a sleep hygiene sheet fails, and how small changes the patient chooses can work.

Clinical takeaways

* Ask what is driving the sleep problem before choosing a drug. Most psychiatric illnesses come with sleep disruption, and the hosts note that the trials behind the guidelines mostly exclude psychiatric patients.

* Screen first. Take a sleep history for snoring, gasping and daytime sleepiness (a STOP-BANG if suspicious), and consider a circadian disorder, where melatonin timing and bright light fit better than a sedative. Sedatives are a concern in untreated sleep apnea.

* Check caffeine, alcohol, cannabis and late-night screen use. If a patient cannot stop for a trial period, a substance use disorder may be the issue.

* In bipolar disorder, stabilize mood and sleep together and avoid agents that could destabilize mood. The hosts disagree on trazodone and mirtazapine: one avoids them, the other uses them at lower doses.

* In psychosis, many antipsychotics can be given once at night, which helps sleep and reduces daytime sedation. Higher doses of ziprasidone are an exception because absorption from one meal is limited.

* For trauma nightmares the hosts consider trazodone, prazosin (watch blood pressure), gabapentin and imagery rehearsal therapy. On sleep hygiene, ask what the patient is willing to change by the next visit, for example charging the phone outside the bedroom.

Read the full transcript

The complete transcript of this episode is on psycho.farm: Insomnia and Sleep Medications in Psychiatry.

Related episodes

* Sleep Medications Treatment Tier List: Best Insomnia Medications Ranked

* Beyond Medications: The Best Lifestyle Treatments for Mental Health

* PTSD Medications: Integrating Pharmacotherapy, Therapy, and the Treatment Frame | Episode 22

For education only. Not medical advice.



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit psychofarm.substack.com